All Policy articles
-
OpinionTrump steps up pharma tariff threat
Taxing branded drug imports could hit biotech innovators hardest
-
NewsEU export of pesticides banned in bloc continues to increase despite commitment to end practice
Investigation of export notifications reveals prohibited agrichemical exports has risen by 50%
-
OpinionA global petrochemical shift
China’s rapid capacity expansion fuels global oversupply, leading plant closures in Europe and elsewhere
-
BusinessNovo Nordisk’s new chief cuts 9000 jobs
Danish firm shifts strategy after struggling to capitalise on its weight loss drugs
-
OpinionIs UK pharma really ‘uninvestable’?
Merck & Co, AstraZeneca (AZ) and Eli Lilly pulling UK projects highlights the precarious position of the country’s life sciences industry
-
OpinionKarl Mueller: ‘I realised I had matured when I started giving away my best ideas’
The director of Ames National Laboratory in the US discusses getting hooked on chemistry via parental inspiration and a benchtop NMR
-
BusinessUK loses life sciences investment as pharma companies halt expansion plans
Industry seeks greater share of healthcare spending to support innovation
-
OpinionUK biofuels burning out
With UK plants facing closure, what are the options and issues around different renewable fuels?
-
NewsDiscussions begin on association of Australia to Horizon Europe
Australia considers joining 20 other non-EU countries in world’s largest research programme
-
BusinessUK biofuels production collapsing in face of cheap imports
Bioethanol plants closing after US tariffs removed, while biodiesel faces competition from China
-
NewsProposal to limit US student visa durations draws criticism
Academic groups warn that the proposed rule will deter talented researchers, harm the economy and add bureaucracy
-
BusinessPharma sector jolted by unpredictable US tariffs policy
Firms face tough decisions amid Trump’s threatened taxes on pharmaceutical imports and ‘capricious’ approach to tariffs
-
NewsTrump’s latest rule on research grants sidelines scientific merit and adds bureaucracy, academic groups warn
A new White House directive will see political appointees vet federal research funding decisions
-
OpinionCheap virgin plastic limits recycling potential
Global plastic treaty negotiations risk being derailed by minority opposed to production caps
-
News‘It’s carnage’: Former NIH director decries Trump administration efforts to slash research spending
Elias Zerhouni tells Chemistry World what’s changed from when he was appointed by a Republican president to the current Trump administration
-
NewsUS government cancels mRNA vaccine research
Experts fear industrial and academic research may move abroad after infectious disease projects cancelled
-
OpinionIntergovernmental panel on chemicals, waste and pollution needs diverse input
Balancing industrial expertise against unwanted commercial influence is not easy but shouldn’t be discounted
-
CareersThe additional costs of visas
On top of the financial expense, applications and renewals are slowing scientific progress and damaging researcher mental health
-
News‘An act of national self-harm’: UK visa system deters top chemistry talent
Immigration policies are making it much more difficult to get scientific talent to come to the UK at a time of global flux
-
NewsThe UN’s new scientific panel on chemical pollution faces an uncertain future
While the panel’s creation was welcomed, experts and researchers express doubts about its ambitions and structure